MSCI

1. $MSFT (+0.86%) sells its leading software and services to both consumers and enterprises. The company's Azure cloud platform and Office 365 suite have significantly driven growth. Microsoft generates 50% of its revenue from the US and 50% internationally. Millions of individuals and businesses worldwide rely on Microsoft's software and productivity tools for their daily operations. Future growth should be propelled by its cloud services, AI and strong enterprise software demand.

-- FCF ROC: 19% I FCF Growth: 15% I FCF Linearity: 0.95 --

2.$MA (+0.05%) a major player in global payments processing, offers credit, debit and prepaid cards, along with digital payment solutions to consumers and businesses worldwide. Mastercard processes close to $6tn transactions per year. Mastercard generates 35% of its revenue from the Americas and the rest internationally. Like Visa, growth has been driven by the shift from cash to digital payments and expanding global commerce. Mastercard's extensive network, strong brand and advanced security measures offer a significant competitive edge.

-- FCF ROC: 42% I FCF Growth: 15% I FCF Linearity: 0.95 --

3. $MSCI (+0.37%) sells investment decision support tools, including indices, portfolio risk and performance analytics, to institutional investors globally. Over $1 trillion in ETF assets are linked to MSCI indexes. Growth has been driven by the increasing adoption of its indices for benchmarking and passive investment products like ETFs. MSCI's strong brand reputation, comprehensive data and analytics capabilities give it its competitive advantage.

-- FCF ROC: 31% I FCF Growth: 18% I FCF Linearity: 1.00 --

4. $CDNS (+0.13%) sells electronic design automation (EDA) software predominantly to the semiconductor industry. 44% of revenue is from the US. Cadence has benefited from the increasing complexity of chip designs and the demand for advanced electronic devices. Its competitive advantages include a comprehensive suite of design tools and long-standing industry relationships. Cadence is well-positioned to capitalise on its critical role in the design process.

-- FCF ROC: 31% I FCF Growth: 19% I FCF Linearity: 0.99 --

5. $FTNT (-1.2%) provides cybersecurity, including firewalls, antivirus software, intrusion prevention systems and endpoint security, to enterprises and service providers. They have over 730,000 customers across most industries, including healthcare, finance, tech and government. Future growth drivers include the expanding cybersecurity market, adoption of cloud security and growing demand for secure network solutions.

-- FCF ROC: 49% I FCF Growth: 27% I FCF Linearity: 0.99 --

wealth.builder101

@wealth_builder101

1Mon·

My investable universe

When I‘m screening markets for my investable universe I look for high-quality compounders with:

Strong and consistent capital returns (ROCE)
High and stable profitability (gross, operating, and FCF margins)
Steady revenue growth over time
Large market capitalization (mature, established companies)

In detail I’m screening for:

Market Cap: at least $ 10B
ROCE 3-Year Avg: ≥ 25%
ROCE 10-Year Avg: ≥ 25%
Gross Margin 3-Year Avg: ≥ 50%
FCF Margin 3-Year Avg: ≥ 20%
Operating Margin 10-Year Avg: ≥ 25%
Revenue per share CAGR 3-Year: ≥ 5%
Revenue per share CAGR 10-Year: ≥ 5%
FCF per share CAGR 3-Year: ≥ 10%
FCF per share CAGR 10-Year: ≥ 10%
Consistency/stability of earnings (from max. 1.0): ≥ 0.8
No more than 75% revenue exposure to one single country/market (eg. USA)

Here are my current holdings:

1Mon·

My Portfolio

Today I‘m sharing with you my main portfolio. This doesn’t include any ETF investments and crypto currencies / gold etc. since I want to focus my presence on getquin on stock-picking.

Read my 3-part portfolio strategy posts to get the full picture - here are just the main pillars of what I‘m doing:

Long-term buy and hold (average holding time 5+ years at least)
Focus on high-ROIC compounders riding secular trends (top-tier capital efficiency)
High margins, strong FCF growth, large moats (7 powers strategy)
Holding not more than 20 stocks at a time while mainly focusing on US and EU based companies

I like to divide my holdings into „core holdings“ (forever stocks) and „trend picks“ (2030 stocks) as follows:

Core Holdings (“Forever Stocks”):

Growth Picks (“2030 Stocks”):

20Positions

37.12%

4 Comments

risk_taker_1816@risk_taker_1816

1Mon

Amazon 2,5k% Plus damn what’s you’re buy in on that one

•

Show answer

wealth.builder101

@wealth_builder101

1Mon·

My portfolio strategy (part 3)

I use the 7 Powers framework from the book “7 Powers: The Foundations of Business Strategy” by Hamilton Helmer. It’s a killer framework for understanding why some businesses create lasting value and compound returns over time.

Each “Power” is a sustainable strategic advantage that lets a company generate outsized returns for a long time. I ask the 7 questions for each stock I am considering to buy.

1. Counter-Positioning

What it is: A new entrant adopts a superior business model that incumbents can’t copy without damaging their own biz.
Example: Netflix vs. Blockbuster. Blockbuster couldn’t move to streaming without killing its DVD revenue.
Why it matters: Creates asymmetric pressure; the old guard is paralyzed.

2. Scale Economies

What it is: Unit costs drop as volume increases.
Example: Amazon, Costco. Bigger = cheaper = stronger moat.
Why it matters: Hard to compete if you can’t match their cost base.

3. Switching Costs

What it is: Customers stick around because switching is painful.
Example: Adobe Creative Cloud, Microsoft Office, Salesforce.
Why it matters: High retention = stable cash flows = compounding machine.

4. Network Effects

What it is: The product gets better as more people use it.
Example: Meta, Visa, LinkedIn.
Why it matters: Leads to dominance, creates a feedback loop of growth.

5. Branding

What it is: Emotional or symbolic value, not just functional.
Example: L’Oréal, Hermès, Apple.
Why it matters: Lets companies charge premium prices and keeps customers loyal even if alternatives exist.

6. Cornered Resource

What it is: Exclusive access to a critical asset — talent, IP, data, supply.
Example: ASML (EUV tech), Novo Nordisk (Ozempic IP), Ferrari (brand + heritage + team).
Why it matters: If no one else can get it, you win.

7. Process Power

What it is: Unique internal processes that drive efficiency, innovation, or quality — and are hard to copy.
Example: Toyota (lean manufacturing), Amazon (logistics, culture of innovation).
Why it matters: Long-lasting edge baked into the org’s DNA.

If I had to chose one, Network effects would be the most important one for me.

Here are my current holdings:

1Mon·

My portfolio strategy (part 2)

Concentrate on the following sectors: Tech, consumer, healthcare, financial (excluding banks), industrials
Smallest position size 2% / largest position size 15%
Only sell a position when it can be replaced with a position that increases the overall quality of the portfolio
Avoid companies with little to no track record or companies going through a restructuring phase

Here are my current holdings:

2 Comments

1Mon

I see a lot of similarities to my strategy! Could it be that you watch a certain Youtuber with the initials JC? 😏

•

Show answer

Invest2impress

@Invest2impress

1Mon·

Depot update

First of all, thank you for taking the time to read this post🙄 it's getting a bit long😅

As you know, the market has only gone in one direction in recent weeks and months📉, but now the wind seems to have changed 📈

since my portfolio presentation last year, I have now used the correction to some changes in the portfolio, which I would like to share with you 🙃 "Unfortunately" there was no reduction in the portfolio for the time being because there were too many attractive opportunities🥹

At the beginning of April in particular, I massively reduced my cash reserves and expanded or even doubled my positions. I also made a a few new additions in my portfolio begrüßen✌️(I actually had a few stocks inspired by the dear @Aktienhauptmeister 👀) Greetings go out 😆

In my portfolio introduction post, I mentioned that I would like to $DHR (-0.98%) against $SYK (-0.03%) would exchange. Now it has actually been implemented ✅ necessity is the mother of invention, which is why I have also parted with $OR (+0.05%) I also parted with

I didn't want to share all my purchases now, that would be too much, so I'll list what I bought here 🙂

I tried as best I could to increase "every" position in the portfolio a bit🧐

First of all, I'll mention the positions that were further expanded

$VWCE (+0.41%) + ~10k

$GRAB (+3.37%) + ~1k to (3.38)

$BLK (+0.94%) + ~ 1.3k (678)

$ASML (+0.47%) + ~2.7k (555,45)

$GOOGL (+1.98%) + ~ 1.5k (124,66)

$MPWR (-2.8%) + ~ 1.6k (409,21)

$SOFI (-0.29%) + ~ 0.7k (7,78)

$LIN (+0.2%) + ~ 1.1k (388,20)

$QCOM (-0.35%) + ~ 1.5k (113,62)

$CRWD (+0.39%) + ~ 0.9k (289,75)

$MSCI (+0.37%) + ~1.3k (451)

$V (+0.46%) + ~ 1.4K (274)

$AMZN (+1.39%) + ~ 1.4K (159,74/159,34)

$MSFT (+0.86%) + ~ 1.7k (335/337,75)

$MC (+0.4%) + ~ 1.9k (482,31)

$NOVO B (-0.16%) + ~ 2.5k (51,68)

$ABBV (-0.74%) +~ 1.5k (152)

$NVDA (+2.24%) +~ 2k (85,04)

$UNH (-2.04%) +~ 1.7k (336,30)

$PEP (-1.12%) +~ 1.1k (114,97)

$MRK (+3.03%) +~ 1k (67,70)

------------------

now to the new arrivals 🤩 the ones now mentioned below I opened the positions for the first time 😇

$SYK (-0.03%) ~ 2.1k (305,72)

$META (+2.2%) ~ 1.4k (467,30)

$AVGO (+1.78%) ~ 1.1k (156,76)

$ISRG (-0.64%) ~ 1.6k (398,30)

$SPGI (+0.5%) ~ 1.2k (403,22)

$ANET (+2.71%) ~ 1.8k (70,50/58,65)

$UNP (+0.57%) ~ 0.9k (187,56)

$CAT (+1.63%) ~ 1.5k (246,50)

(I hope I have not forgotten anything)

I have invested a total of about 45k and am absolutely satisfied with my investment case. Now I have no more buffer to add 🥲 in the next few months I will build up cash again 😬

Now I'm curious to see what you've bought, my dear investors?

Like for example @Aktienhauptmeister
@Max095
@Tenbagger2024
@Simpson 🫣

thanks again for reading 🥸

in that sense

have a nice weekend ✌️

01.04

Danaher

Sold x5 at €185.08

€925.40

0.96%

23 Comments

Tenbagger2024@Tenbagger2024

1Mon

Danaher has always been hyped in 2023 by a well-known YouTuber or finfluencer on a weekly basis. And once I wrote to him in the comments "That won't work, let him choose another stock". But it didn't stop him 🙈😂.
Intuitive surgil is still the market leader but is facing competition, including from Stryker. But you have both. And robotics is only just beginning and will continue to grow.
Unfortunately, I sold Arista. However, it should continue to benefit from investments in AI.
I'm starting to hate LVMH 🙈. It's been a drag on my portfolio for a long time. And I'd rather sell it today than tomorrow. But somehow I also believe in a recovery and that's why it's staying put for now.
Well, the Apple statement about Google has caused uncertainty at Alphabet. We'll have to see how Google counters this now. But I'm sticking with it for now. And I have already written something about this in another post.
I am somewhat skeptical about Merck due to expiring patents of the blockbuster.
Novo is the market leader, but is facing increasing competition and the pie is getting smaller.
I see more potential in the biotech sector, but the risk here is also greater.
The semiconductor sector will remain volatile. The Chinese are continuing to catch up, see Huawei. And often the smallest announcement is enough to push the sector down again.
But there is still potential.
Whereby phase 2 and phase 3 have long been initiated in the AI sector. And you have to find the pearls here.
I think you're missing a few European or Asian stocks.
And you are quite invested in tech

•

View all 5 further answers

wealth.builder101

@wealth_builder101

2Mon·

My portfolio strategy (part 1)

My Portfolio is a selection of 15-25 companies which I am buying and planning on never selling. The overall criteria for my #investableuniverse are the following. I will go in-depth in another post:

Little capital needed to run the business (high ROCE)
High returns on invested capital (high ROIC)
Profitability track-record with high gross margins / operating margins / high free cash flow margins
High free cashflow growth / substantial revenue growth
Global revenue diversification
Low cyclicality
#tollbooth Company - Large moat / brand name in the industry / no alternatives to the product
Predictable sources of future growth / global trends

Here are my current holdings:

6 Comments

2Mon

i like it !

•

Show answer

@j07k

2Mon·

Purchase Novo Nordisk

$NOVO B (-0.16%)

Now it has happened.

Novo Nordisk has been on my watchlist for some time and is now also part of my portfolio.

The share price has been pushed down quite a bit in recent times, but I think that the company offers strong growth potential and currently even scores with an acceptable dividend yield.

What do you think of my decision to buy?

The next step will probably be $MSCI (+0.37%) stock up.

14.04

Novo Nordisk

Bought x25 at €59.29

€1,482.25

35 Comments

Chris@Multibagger

2Mon

Why? And above all, why now? Trump has specifically announced tariffs for the pharmaceutical sector. And please don't write that it won't matter in the long term. Then you could have already bought at 100

•

View all 23 further answers

Trending Securities

Top creators this week

Real-time data from LSX · Fundamentals & EOD data from FactSet